Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
66.00    0.00 (0.00%)
Bid:
65.20
Ask:
70.00
Spread: 4.80 (7.362%)
Market Cap: £89.08m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

PDMR - Performance conditions for LTIP award

30 Nov 2023 07:00

RNS Number : 1394V
Trifast PLC
30 November 2023
 

 

 

Thursday, 30 November 2023

 

Trifast plc

(the "Company")

 

Performance conditions for LTIP award and Notification and public disclosure of transactions by PDMR

 

The Company announces that, further to the terms set out in the Company's Directors' Remuneration Policy ("Policy") which was approved at the AGM on 15 September 2023, the Remuneration Committee ("Committee") has determined to grant an LTIP award to Iain Percival and Darren Hayes-Powell over the number of ordinary shares of 5p each in the Company ("Ordinary Shares") set out in the table below under the terms of the Trifast plc Employee Share Plan. The LTIP award was granted on 28 November 2023 and no consideration was paid for the grant which is structured as a nil-cost option.

 

PDMR

Number of Shares granted

Iain Percival (CEO)

814,553

Darren Hayes-Powell (CFO)

509,095

 

The number of Ordinary Shares granted under the LTIP award has been calculated using an Ordinary Share price of 73.66 pence per share, being the average share price of the five days immediately before the date of grant.

 

The normal vesting date of the LTIP award will be 26 November 2026, being the third anniversary of the grant date. The LTIP award is subject to a two-year holding period commencing on vesting.

 

The number of Ordinary Shares under the LTIP Award will normally vest after three years based on the satisfaction of performance conditions which are measured over three financial years ending 31 March 2026. As set out in the Company's Directors' Remuneration Report, the Committee determined the performance conditions attached to the award prior to the date of grant to be as follows:

 

· 75% of the LTIP award will be based on relative Total Shareholder Return ("TSR") versus the FTSE All Share Index; and

· 25% of the LTIP award will be based on Underlying Operating Margin ("UOM") performance in FY26.

 

Full details of performance targets are set out below.

 

Relative TSR Target

The TSR growth for Trifast and the FTSE All Share index will be measured using a three-month average prior to the start and the end of the three-year performance period, starting on 1 April 2023. The number of Shares subject to the TSR Target will vest as follows:

 

Trifast's TSR growth

Vesting % achieved*

Below the FTSE All Share Index

Below threshold (Nil)

Equal to the FTSE All Share Index

Threshold (25%)

8% p.a. or above outperformance of the FTSE All Share Index

Maximum (100%)

 

*Vesting between Threshold and Maximum performance is on a straight-line basis.

 

The Committee notes that it was the intention at the date of drafting of the 2023 Annual Report that the FTSE Small Cap index (excluding Investment Trusts) would be used to assess relative TSR performance. However, the Committee has since determined that it would instead use the FTSE All Share index on the basis that this index provides a more appropriate, broader comparison of companies facing similar global challenges to Trifast. Additionally, it is noted that this is consistent with Trifast's Remuneration Policy.

 

UOM Target

The number of Shares subject to the UOM Target will vest as follows based on Trifast's FY26 UOM performance:

 

FY26 UOM** required

Vesting % achieved*

Below 8.2%

Below Threshold (Nil)

8.2%

Threshold (25%)

9.1%

50%

10.0%

75%

11.0% and above

Maximum (100%)

 

*Vesting between the various performance levels will be determined on a straight-line basis.

**UOM is defined as Underlying operating profit as a percentage of sales.

 

 

The notifications below are made in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Iain Percival

2.

Reason for the notification

a.

Position/status

Chief Executive Officer

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

b.

LEI

213800WFIVE6RWK3CR22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the Financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each

GB0008883927

b.

Nature of the transaction

Grant of Award under the Trifast plc Employee Share Plan 2014

c.

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

814,553

d.

Aggregated information

·Aggregated volume

·Price

 

814,553

Nil

e.

Date of the transaction

28.11.23

f.

Place of the transaction

Outside a trading venue

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Darren Hayes-Powell

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

b.

LEI

213800WFIVE6RWK3CR22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the Financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each

GB0008883927

b.

Nature of the transaction

Grant of Award under the Trifast plc Employee Share Plan 2014

c.

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

509,095

d.

Aggregated information

·Aggregated volume

·Price

 

509,095

Nil

e.

Date of the transaction

28.11.23

f.

Place of the transaction

Outside a trading venue

 

 

Enquiries:

Trifast plc

Christopher Morgan

Company Secretary

Tel: +44 (0) 1825 769696

www.trifast.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDDBDBCXDDGXC
Date   Source Headline
3rd Jun 20267:46 amRNSDirector Declaration
5th May 20261:03 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSTrading Statement
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20261:44 pmRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSHolding(s) in Company
27th Mar 20262:53 pmRNSHolding(s) in Company
27th Mar 20262:43 pmRNSDirector/PDMR Shareholding
17th Feb 20261:15 pmRNSDirector/PDMR Shareholding
16th Feb 20263:02 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSTrading Statement
19th Jan 20268:34 amRNSDirector Declaration
9th Jan 202611:02 amRNSDirector/PDMR Shareholding
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSHalf-year Financial Report
23rd Oct 20255:10 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSTrading Statement
15th Oct 20253:06 pmRNSDirector/PDMR Shareholding
7th Oct 20259:01 amRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNSBoard Fellow Appointment
11th Sep 20251:31 pmRNSResult of AGM
11th Sep 20257:00 amRNSTrading Statement
5th Sep 20253:00 pmRNSDirector/PDMR Shareholding
18th Aug 20251:21 pmRNSDirector/PDMR Shareholding
28th Jul 20253:19 pmRNSDirector/PDMR Shareholding
22nd Jul 20258:08 amRNSNotice of AGM
14th Jul 20251:44 pmRNSDirector/PDMR Shareholding - Replacement
14th Jul 20251:17 pmRNSDirector/PDMR Shareholding
10th Jul 20257:00 amRNSFinal Results
27th Jun 20252:50 pmRNSNotice of Results
4th Jun 20257:00 amRNSTotal Voting Rights
19th May 20255:02 pmRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Update & Notice of FY25 Annual Results
16th Apr 20253:02 pmRNSShare purchases under Dividend Re-Investment Plan
11th Apr 20257:00 amRNSDirector/PDMRs share purchases
2nd Apr 20251:25 pmRNSBlock listing Interim Review
27th Mar 20252:15 pmRNSDirector/PDMR Shareholding
24th Mar 202512:12 pmRNSDirector/PDMR Shareholding - Purchase of Shares
13th Feb 20257:00 amRNSTrading update
5th Feb 202511:19 amRNSDirector/PDMR Shareholding
4th Feb 20253:54 pmRNSDirector/PDMR Shareholding
28th Jan 20252:07 pmRNSDirector/PDMR Shareholding
27th Jan 20255:15 pmRNSDirector/PDMR Shareholding
23rd Jan 20255:27 pmRNSHolding(s) in Company
11th Dec 20241:58 pmRNSHolding(s) in Company
11th Dec 20241:55 pmRNSDirector/PDMR Shareholding
10th Dec 20243:23 pmRNSTotal Voting Rights
29th Nov 202411:15 amRNSChange of Auditor & Registered office address

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.